- Home
- SXTP vs NAOV Comparison
SXTP vs NAOV Comparison
Compare SXTP & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SXTP | NAOV |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 4.1M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SXTP | NAOV |
|---|---|---|
| Price | $0.80 | $4.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.40 | N/A |
| AVG Volume (30 Days) | ★ 82.6K | 31.0K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,364,945.00 | ★ $2,685,000.00 |
| Revenue This Year | $146.28 | N/A |
| Revenue Next Year | $24.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 202.10 | N/A |
| 52 Week Low | $0.84 | $3.55 |
| 52 Week High | $11.35 | $162.50 |
Technical Indicators
Market Signals| Indicator | SXTP | NAOV |
|---|---|---|
| Relative Strength Index (RSI) | 23.94 | 43.18 |
| Support Level | $0.84 | $3.83 |
| Resistance Level | $0.98 | $4.74 |
| Average True Range (ATR) | 0.08 | 0.45 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 3.64 | 25.97 |
Price Performance
Historical ComparisonAbout SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.